You’re offline. This is a read only version of the page.
Our AI-driven technology, Thermalytix®, has undergone extensive clinical validation, demonstrating 95% sensitivity in detecting breast abnormalities. By analysing thermal patterns, Thermalytix® identifies subtle changes in breast tissue, often up to five years before a lump forms, making early intervention possible.
Sensitivity for breast abnormality detection - Proven effectiveness in identifying abnormalities before traditional methods.
Screenings Conducted – A growing dataset that enhances AI precision and learning.
of reports reviewed both by AI & a registered radiologist - Ensuring issues do not go unidentified.
At Ada & Me, innovation drives everything we do, and now it’s here to empower you.
Our vision to transform breast health started with a simple belief: everyone deserves access to safe, stress-free, and inclusive screening. Guided by our principles of Empowerment, Inclusion, and Compassionate Care, we bring to you Thermalytix®, an AI-powered technology that combines thermal imaging with advanced algorithms to detect abnormalities with 95% sensitivity—up to five years before a lump forms.
What makes our approach revolutionary isn’t just the science but the experience. Our screening is non-invasive, radiation-free, and contact-free, ensuring your safety and comfort while delivering results you can trust. Every detail is designed to prioritise you—because breast health should never feel intimidating.
With over 300,000 screenings completed, we’re creating a future where breast health is simple, empowering, and refreshingly modern. At Ada & Me, we’re not just saving lives—we’re giving you the confidence to take charge of your health with care and connection every step of the way.
Our science
